Conavi Medical (TSE:CNVI) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Conavi Medical’s Novasight Hybrid System, which uniquely combines IVUS and OCT for comprehensive coronary artery imaging, has been highlighted in a peer-reviewed article for its potential to improve cardiovascular procedures. This innovative technology is currently being showcased at the TCT 2024 conference, emphasizing its promising future in enhancing patient care.
For further insights into TSE:CNVI stock, check out TipRanks’ Stock Analysis page.